Trial Profile
Safety and efficacy of Tranilast for the treatment of relapsed or resistant lymphoid tumors; a pilot study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Feb 2014
Price :
$35
*
At a glance
- Drugs Tranilast (Primary)
- Indications Lymphoid leukaemia; Lymphoma
- Focus Adverse reactions
- 21 Jun 2012 New trial record